Breast cancer patients with early-stage cancer may opt for breast-conserving surgery -- either a lumpectomy (wide local excision) -- removal only of the "lump" of tumor as well as the normal breast tissue closely surrounding the tumor, or partial mastectomy -- removal of the tumor and a larger portion of surrounding breast tissue. This is usually followed by radiation therapy.
In inflammatory breast cancer, cancer has spread to the skin of the breast and the breast looks red and swollen and feels warm. The redness and warmth occur because the cancer cells block the lymph vessels in the skin. The skin of the breast may also show the dimpled appearance called peau d'orange (like the skin of an orange). There may not be any lumps in the breast that can be felt. Inflammatory breast cancer may be stage IIIB, stage IIIC, or stage IV.
Inflammatory breast cancer...
If the cancer is advanced, if there is a high risk of recurrence, or if the surgeon cannot remove all necessary breast tissue (surgical margins) with breast-conserving surgery, the surgeon may recommend a mastectomy, which is complete removal of the breast. Some women choose to have breast reconstruction following mastectomy.
At the time of surgery, most patients also have either sentinel node biopsy or axillary node dissection to determine if the breast cancer cells have spread to the lymph nodes. These procedures remove lymph nodes from the armpit to test them for cancer cells. Sentinel lymph node biopsies have largely replaced axillary node dissection.
Surgery is often combined with additional treatments, known as adjuvant therapy, to destroy any remaining cancer cells. Sometimes, the additional treatment may be given before surgery (called neoadjuvant therapy) when the breast cancer has been found to have already spread widely. These methods of treatment include:
Stage of the breast cancer, including whether cancer has spread to your lymph nodes
The type of cancer and whether the cancer is an aggressive type
Whether you have gone through menopause
Whether the cancer you have depends on female hormones to grow; if it is "sensitive" to the female hormones, then the cancer is called "endocrine-receptor positive" (ER and/or PR positive). If not, it is ER/PR negative. This is determined by testing a tissue sample in the lab.
The presence of other markers such as the HER2 protein
Most doctors who treat cancer patients in the U.S. follow national guidelines set by the National Comprehensive Cancer Network (NCCN) and/or the American Society of Clinical Oncology (ASCO), which have helped improve patient care. Still, treatment will vary based on your needs and circumstances.
Before you begin treatment for breast cancer, print out these questions to ask your specialists so you can better understand your care: Questions to Ask.